LPL Financial’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.8K | Sell |
17,114
-1,462
| -8% | -$1.74K | ﹤0.01% | 6131 |
|
|
2026
Q1 | $32.3K | Sell |
18,576
-37
| -0.2% | -$61 | ﹤0.01% | 5829 |
|
|
2025
Q4 | $32.4K | Sell |
18,613
-7,382
| -28% | -$16.3K | ﹤0.01% | 5757 |
|
|
2025
Q3 | $60.8K | Buy |
25,995
+9,039
| +53% | +$17.3K | ﹤0.01% | 5606 |
|
|
2025
Q2 | $34.5K | Buy |
16,956
+4,759
| +39% | +$9.12K | ﹤0.01% | 5410 |
|
|
2025
Q1 | $19.9K | Buy |
+12,197
| New | +$24.5K | ﹤0.01% | 5256 |
|
|
2024
Q1 | – | Sell |
-1,357
| Closed | -$8.3K | – | 4973 |
|
|
2023
Q4 | $8.3K | Buy |
1,357
+61
| +5% | +$301 | ﹤0.01% | 4764 |
|
|
2023
Q3 | $6.05K | Sell |
1,296
-246
| -16% | -$1.36K | ﹤0.01% | 4667 |
|
|
2023
Q2 | $8.26K | Sell |
1,542
-121
| -7% | -$975 | ﹤0.01% | 4568 |
|
|
2023
Q1 | $16.4K | Sell |
1,663
-1,292
| -44% | -$22K | ﹤0.01% | 4429 |
|
|
2022
Q4 | $55.3K | Sell |
2,955
-70
| -2% | -$1.59K | ﹤0.01% | 4246 |
|
|
2022
Q3 | $63K | Sell |
3,025
-341
| -10% | -$8.73K | ﹤0.01% | 4199 |
|
|
2022
Q2 | $70K | Sell |
3,366
-2,666
| -44% | -$75.1K | ﹤0.01% | 4188 |
|
|
2022
Q1 | $260K | Buy |
6,032
+1,736
| +40% | +$78.2K | ﹤0.01% | 3683 |
|
|
2021
Q4 | $257K | Buy |
4,296
+168
| +4% | +$13.5K | ﹤0.01% | 3802 |
|
|
2021
Q3 | $355K | Sell |
4,128
-1,109
| -21% | -$111K | ﹤0.01% | 3511 |
|
|
2021
Q2 | $583K | Buy |
5,237
+943
| +22% | +$90.6K | ﹤0.01% | 3025 |
|
|
2021
Q1 | $478K | Buy |
4,294
+463
| +12% | +$60.9K | ﹤0.01% | 3058 |
|
|
2020
Q4 | $407K | Buy |
3,831
+82
| +2% | +$10.9K | ﹤0.01% | 2939 |
|
|
2020
Q3 | $522K | Sell |
3,749
-2,186
| -37% | -$456K | ﹤0.01% | 2422 |
|
|
2020
Q2 | $1.92M | Buy |
5,935
+1,263
| +27% | +$203K | ﹤0.01% | 1367 |
|
|
2020
Q1 | $417K | Buy |
4,672
+1,330
| +40% | +$82K | ﹤0.01% | 2215 |
|
|
2019
Q4 | $132K | Buy |
3,342
+425
| +15% | +$12.8K | ﹤0.01% | 3189 |
|
|
2019
Q3 | $72K | Buy |
2,917
+1,184
| +68% | +$36K | ﹤0.01% | 3180 |
|
|
2019
Q2 | $61K | Buy |
+1,733
| New | +$68.8K | ﹤0.01% | 3191 |
|
|
2016
Q3 | – | Sell |
-933
| Closed | -$103K | – | 2694 |
|
|
2016
Q2 | $103K | Sell |
933
-919
| -50% | -$112K | ﹤0.01% | 2503 |
|
|
2016
Q1 | $198K | Buy |
1,852
+735
| +66% | +$56.7K | ﹤0.01% | 2796 |
|
|
2015
Q4 | $84K | Buy |
1,117
+173
| +18% | +$13.8K | ﹤0.01% | 3011 |
|
|
2015
Q3 | $70K | Buy |
944
+67
| +8% | +$5.84K | ﹤0.01% | 2692 |
|
|
2015
Q2 | $83K | Sell |
877
-210
| -19% | -$22.4K | ﹤0.01% | 2771 |
|
|
2015
Q1 | $110K | Buy |
+1,087
| New | +$105K | ﹤0.01% | 2666 |
|
|
2014
Q2 | – | Sell |
-290
| Closed | -$46K | – | 2715 |
|
|
2014
Q1 | $46K | Buy |
+290
| New | +$41.6K | ﹤0.01% | 2592 |
|
Other funds holding INO
JT
BCM
ACM
EP
LPL Financial's INO Position: Q2 2026 in Review
LPL Financial reduced its Inovio Pharmaceuticals (INO) stake by 7.9% in Q2 2026, selling an estimated $1.74K and leaving 17,114 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6131.
LPL Financial first reported a position in INO in Q1 2014 and has held it in 32 quarters since. The position peaked at $1.92M in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.
- LPL Financial held 17,114 shares of Inovio Pharmaceuticals worth $18.8K as of Q2 2026.
- LPL Financial sold 1,462 Inovio Pharmaceuticals shares in Q2 2026, an estimated $1.74K.
- Inovio Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6131 holding.
- LPL Financial first reported a position in Inovio Pharmaceuticals in Q1 2014 and has held it in 32 quarters since.
- LPL Financial's Inovio Pharmaceuticals position peaked at $1.92M in Q2 2020.
- 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.